Theseus Pharmaceuticals Inc (THRX) Financials

$4.06

$0.00 (0.00%)

As on 23-Feb-2024 09:30EDT

Market cap

$181 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.49	0.44	0.00	0.00	0.00	--
Gross Profit	-0.49	-0.44	0.00	0.00	0.00	--
Operating Expenses	66.52	54.09	27.34	6.84	4.94	--
Operating Profit (EBIT)	-66.52	-54.09	-27.34	-6.84	-4.94	--
Other Income	7.18	3.09	0.03	--	--	--
Profit before Tax	-56.61	-50.61	-27.31	-12.00	-7.18	--
Provision for Tax	-0.78	-3.53	-0.03	5.16	2.24	--
Profit after Tax (Net Income)	-55.86	-47.08	-27.31	-12.00	-7.18	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-43.11	-50.61	-27.31	-12.00	-7.18	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	224.52	207.62	246.43	-34.27	-9.41	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.10	3.70	0.82	41.29	10.22	--
Current Liabilities	7.00	11.13	3.68	1.60	0.62	--
Total Liabilities	241.63	222.45	250.93	8.61	1.43	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	25.04	24.47	2.96	0.04	0.05	--
Current Assets	209.59	197.98	247.97	8.57	1.38	--
Total Assets	241.63	222.45	250.93	8.61	1.43	--
Total Debt*	3.66	3.98	--	--	--	--
Net Current Assets	202.58	190.99	244.29	6.98	0.77	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-32.95	-27.19	-4.85	-4.81	--
Cash Flow from Investing Activities	--	-117.29	0.01	-117.29	-117.29	--
Cash from Financing Activities	--	0.18	263.78	11.99	2.99	--
Net Cash Inflow / Outflow	--	-150.06	236.60	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.33	-1.22	-0.76	-0.47	--	--
Cash EPS ($)	--	-1.22	-0.76	-0.47	--	--
Adjusted Book Value ($)	--	5.36	6.87	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.85	-0.76	-0.19	--	--
Free Cash Flow per Share ($)	--	-0.86	-0.76	-0.19	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-20.56	-25.74	54.94	--	--
ROE (%)	-23.77	-20.74	-25.74	54.94	--	--
ROA (%)	-23.29	-19.89	-21.04	-238.96	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-778.31	-1,522.64	-97,528.57	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-40.88	-97.86	-299.88	-38.32	--	--
Net Profit Growth (%)	-27.44	-72.40	-127.62	-67.02	--	--
EPS Growth (%)	-15.13	-0.60	-0.61	--	--	--
Book Value Growth (%)	-9.52	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-4.09	-16.66	--	--	--
Price / Book Value	0.81	0.93	1.85	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.30	0.02	-7.69	--	--	--
Close Price ($)	2.69	4.98	12.68	--	--	--
High Price ($)	14.77	15.21	24.54	--	--	--
Low Price ($)	2.60	4.01	8.65	--	--	--
Market Cap ($ Cr)	181.28	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.02	--	--	--	--
Short term debt to equity ratio	0.00	0.00	--	--	--	--
Current Ratio	29.93	17.79	67.38	5.37	2.25	--
Quick Ratio	29.93	--	--	--	--	--
Interest Coverage	-12.53	-15.33	-976.29	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	2,491.29	194,860.88	129,389.81	52,048.13	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.